I  U  P  A  C

 

 

 

News & Notices

Organizations & People

Standing Committees

Divisions

Projects

Reports

Publications
. . CI
. . PAC
. . Macro. Symp.

. . Books
. . Solubility Data

Symposia

AMP

Links of Interest

Search the Site

Home Page

 

Pure Appl. Chem. 76(9), 1659-1677, 2004

Pure and Applied Chemistry

Vol. 76, Issue 9

From synthetic polyelectrolytes to polymer-subunit vaccines

V. A. Kabanov

Department of Chemistry, M. V. Lomonosov Moscow State University, Leninskie Gory, Moscow 119992, Russia

Abstract: The results of many years of collaborative research by chemists and immunologists in the area of application of synthetic polyelectrolytes in immunology are reviewed. Linear synthetic polyelectrolytes with diverse structures (which are not structural analogs of biopolymers and, hence, not antigenic because they are unknown to the immune system), when introduced into the organism, noticeably intensify the formation, migration, and dissemination of stem cells, which are precursors of all specialized cells including functional immune cells. In addition, synthetic polyelectrolytes, when introduced in mixtures with typical antigens (proteins, natural microbial polysaccharides, and their synthetic analogs), serve as immunostimulants enhancing immune response by several times. Moreover, individual bacterial or viral antigens, not sufficiently active by themselves, induce specific immune response enhanced by orders of magnitude if chemically bound to synthetic polyelectrolytes. Such conjugates being preliminarily administrated, protect organisms from absolutely mortal doses of the corresponding bacteria or viruses. The nontoxic immunostimulant was developed: the ternary copolymer of 1,4-ethylenepiperazine,1,4-ethylenepiperazine-N-oxide, and (N -carboxymethylene)-1,4-ethylenepiperazinium bromide (brand name �polyoxidonium ��) permitted for human administration. The conjugate of polyoxidonium with hemagglutinin and neuraminidase, protein subunits of influenza viruses, has appeared as the first non-Pasteurian vaccine, which now is successfully used in Russia (about 50 million immunized people for the last 7 years). The physicochemical mechanisms of the biological effect of these compounds and challenges of the further use of the approach developed are considered in the review.

*Plenary lecture presented at the XVII Mendeleev Congress on General and Applied Chemistry, Kazan, Tatarstan, Russia, 21 -26 September 2003. Other presentations are published in this issue, pp. 1605-1798.


Page last modified 23 September 2004.
Copyright © 2004 International Union of Pure and Applied Chemistry.
Questions or comments about IUPAC, please contact, the Secretariat.
Questions regarding the website, please contact web manager.